What drugs does GALDERMA LABS make?

GALDERMA LABS has 2 FDA-approved drugs including EPIDUO FORTE.

What therapeutic areas does GALDERMA LABS focus on?

GALDERMA LABS focuses primarily on Dermatology and Immunology.

← Back

Data updated: Mar 10, 2026

GALDERMA LABS

DermatologyImmunology

Pharma

GALDERMA LABS is a pharmaceutical company focused on Dermatology, Immunology. Key products include EPIDUO FORTE.

2004

Since

Drugs

Trials

Approved (2yr)

Key Drugs

EPIDUO FORTE

adapalene

Retinoic acid receptor 1 indications · 2015

Recent Activity

No recent activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 67%

2 drugs

Immunology 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Dermatology, Immunology

Eli Lilly big-pharma

Immunology, Dermatology

BAUSCH specialty

Dermatology, Immunology

COSETTE other

Dermatology, Immunology

BAUSCH AND LOMB specialty

Dermatology, Immunology

GALDERMA LABS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (2)

Active (2)

Discontinued (0)

Company Info